Methods for fine-mapping with chromatin and expression data

PLoS Genetics
Megan RoytmanBogdan Pasaniuc

Abstract

Recent studies have identified thousands of regions in the genome associated with chromatin modifications, which may in turn be affecting gene expression. Existing works have used heuristic methods to investigate the relationships between genome, epigenome, and gene expression, but, to our knowledge, none have explicitly modeled the chain of causality whereby genetic variants impact chromatin, which impacts gene expression. In this work we introduce a new hierarchical fine-mapping framework that integrates information across all three levels of data to better identify the causal variant and chromatin mark that are concordantly influencing gene expression. In simulations we show that our method is more accurate than existing approaches at identifying the causal mark influencing expression. We analyze empirical genetic, chromatin, and gene expression data from 65 African-ancestry and 47 European-ancestry individuals and show that many of the paths prioritized by our method are consistent with the proposed causal model and often lie in likely functional regions.

References

Jul 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·John D Storey, Robert Tibshirani
Mar 2, 2010·Nature Genetics·Patrick C A DuboisDavid A van Heel
Jul 22, 2010·The New England Journal of Medicine·Teri A Manolio
Mar 29, 2011·Nature·Jason ErnstBradley E Bernstein
Aug 13, 2011·Nature·UNKNOWN International Multiple Sclerosis Genetics ConsortiumAlastair Compston
Jan 17, 2012·American Journal of Human Genetics·Peter M VisscherJian Yang
Feb 7, 2012·Nature·Jacob F DegnerJonathan K Pritchard
Sep 8, 2012·Science·Matthew T MauranoJohn A Stamatoyannopoulos
Oct 30, 2012·Nature Genetics·UNKNOWN Wellcome Trust Case Control ConsortiumPeter Donnelly
Nov 7, 2012·Nature·UNKNOWN 1000 Genomes Project ConsortiumGil A McVean
Sep 17, 2013·Nature·Tuuli LappalainenEmmanouil T Dermitzakis
Oct 19, 2013·Science·Maya KasowskiMichael Snyder
Oct 19, 2013·Science·Graham McVickerJonathan K Pritchard
Jan 7, 2014·Nature·Yukinori OkadaRobert M Plenge
Aug 12, 2014·Genetics·Farhad HormozdiariEleazar Eskin
Feb 20, 2015·Nature·UNKNOWN Roadmap Epigenomics ConsortiumManolis Kellis
Feb 25, 2015·Nature Reviews. Genetics·Frank W Albert, Leonid Kruglyak
Feb 26, 2015·Nature Genetics·Joshua J Waterfall, Paul S Meltzer
Aug 25, 2015·Cell·Sebastian M WaszakEmmanouil T Dermitzakis
Apr 30, 2016·Science·Yang I LiJonathan K Pritchard
Nov 22, 2016·American Journal of Human Genetics·Farhad HormozdiariEleazar Eskin

❮ Previous
Next ❯

Citations

May 6, 2019·Cell Systems·Christopher M Jakobson, Daniel F Jarosz

❮ Previous
Next ❯

Methods Mentioned

BETA
PCA

Software Mentioned

eCAVIAR
ChromHMM
HaploReg
pathfinder
Coloc

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.